Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–74.

Article  PubMed  Google Scholar 

Riedl D, Schuessler G. Prevalence of depression and cancer–a systematic review. Z Psychosom Med Psychother. 2021;68(1):74–86.

PubMed  Google Scholar 

Brandenbarg D, Maass SW, Geerse OP, Stegmann ME, Handberg C, Schroevers MJ, et al. A systematic review on the prevalence of symptoms of depression, anxiety and distress in long-term cancer survivors: implications for primary care. Eur J Cancer Care. 2019;28(3):e13086.

Google Scholar 

Mejareh ZN, Abdollahi B, Hoseinipalangi Z, Jeze MS, Hosseinifard H, Rafiei S, et al. Global, regional, and national prevalence of depression among cancer patients: A systematic review and meta-analysis. Indian J psychiatry. 2021;63(6):527–35.

Article  PubMed  PubMed Central  Google Scholar 

Dong ST, Costa DS, Butow PN, Lovell MR, Agar M, Velikova G, et al. Symptom clusters in advanced cancer patients: an empirical comparison of statistical methods and the impact on quality of life. J Pain Symptom Manage. 2016;51(1):88–98.

Article  PubMed  Google Scholar 

Arrieta Ó, Angulo LP, Núñez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Martínez-López D, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2013;20:1941–8.

Article  PubMed  Google Scholar 

Mausbach BT, Schwab RB, Irwin SA. Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2015;152:239–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DiMatteo MR, Haskard-Zolnierek KB. Impact of depression on treatment adherence and survival from cancer. Depress Cancer. 2011:101–24.

Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol. 2005;5(3):243–51.

Article  CAS  PubMed  Google Scholar 

Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5(10):617–25.

Article  CAS  PubMed  Google Scholar 

Sotelo JL, Musselman D, Nemeroff C. The biology of depression in cancer and the relationship between depression and cancer progression. Int Rev Psychiatry. 2014;26(1):16–30.

Article  PubMed  Google Scholar 

Marinovic DA, Hunter RL. Examining the interrelationships between mindfulness-based interventions, depression, inflammation, and cancer survival. CA Cancer J Clin. 2022;72(5):490–502.

PubMed  Google Scholar 

Zhang L, Pan J, Chen W, Jiang J, Huang J. Chronic stress-induced immune dysregulation in cancer: implications for initiation, progression, metastasis, and treatment. Am J Cancer Res. 2020;10(5):1294.

CAS  PubMed  PubMed Central  Google Scholar 

Wang Y-H, Li J-Q, Shi J-F, Que J-Y, Liu J-J, Lappin JM, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020;25(7):1487–99.

Article  PubMed  Google Scholar 

Wang X, Wang N, Zhong L, Wang S, Zheng Y, Yang B, et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Mol Psychiatry. 2020;25(12):3186–97.

Article  PubMed  PubMed Central  Google Scholar 

Walker J, Mulick A, Magill N, Symeonides S, Gourley C, Burke K, et al. Major depression and survival in people with cancer. Psychosom Med. 2021;83(5):410–6.

Article  PubMed  PubMed Central  Google Scholar 

Kissane D. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology. 2009;18(1):1–5.

Article  PubMed  Google Scholar 

Zingone A, Brown D, Bowman ED, Vidal OM, Sage J, Neal J, et al. Relationship between anti-depressant use and lung cancer survival. Cancer Treat Res Commun. 2017;10:33–9.

PubMed  PubMed Central  Google Scholar 

Stagl JM, Lechner SC, Carver CS, Bouchard LC, Gudenkauf LM, Jutagir DR, et al. A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up. Breast Cancer Res Treat. 2015;154:319–28.

Article  PubMed  PubMed Central  Google Scholar 

Ng CG, Boks MP, Smeets HM, Zainal NZ, de Wit NJ. Prescription patterns for psychotropic drugs in cancer patients; a large population study in the Netherlands. Psychooncology. 2013;22(4):762–7.

Article  PubMed  Google Scholar 

Sanjida S, Janda M, Kissane D, Shaw J, Pearson SA, DiSipio T, et al. A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients. Psychooncology. 2016;25(9):1002–16.

Article  PubMed  Google Scholar 

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: A clinical practice guideline from the american college of physicians. Ann Intern Med. 2016;165(2).

Walsh JK, Roth T. Pharmacologic treatment of insomnia: Benzodiazepine receptor agonists. In: Kryger MH, Roth T, Dement WC, editors. Principles and practices of sleep medicine. 5th ed. Glendenning, Australia: Saunders; 2011. pp. 905–15.

Chapter  Google Scholar 

Buysse DJ. Insomnia. JAMA. 2013;309(7):706–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lovato N, Lack L. Insomnia and mortality: a meta-analysis. Sleep Med Rev. 2019;43:71–83.

Article  PubMed  Google Scholar 

Wernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA. Use of antidepressants and NSAIDs in relation to mortality in long‐term breast cancer survivors. Pharmacoepidemiol Drug Saf. 2011;20(2):131–7.

Article  PubMed  Google Scholar 

Chen P-L, Lee W-J, Sun W-Z, Oyang Y-J, Fuh J-L. Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS One. 2012;7(11):e49113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee J, Jung SJ, Choi J-w, Shin A, Lee YJ. Use of sedative-hypnotics and the risk of Alzheimer’s dementia: a retrospective cohort study. PLoS One. 2018;13(9):e0204413.

Article  PubMed  PubMed Central  Google Scholar 

Kripke DF, Langer RD, Kline LE. Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ Open. 2012;2(1):e000850.

Article  PubMed  PubMed Central  Google Scholar 

Deleemans JM, Mather H, Spiropoulos A, Toivonen K, Baydoun M, Carlson LE. Recent progress in mind–body therapies in cancer care. Curr Oncol Rep. 2023;25(4):293–307.

Article  PubMed  Google Scholar 

Elkins G, Fisher W, Johnson A. Mind–body therapies in integrative oncology. Curr Treat Options Oncol. 2010;11:128–40.

Article  PubMed  Google Scholar 

Vollbehr NK, Schmidt AT, Bartels-Velthuis AA, Ostafin BD, Hoenders HR. The ethics of yoga in (mental) healthcare: beyond the traditional Eightfold path. Complement Ther Med. 2023;77:102979.

Article  PubMed  Google Scholar 

Kabat-Zinn J, Hanh TN. Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness. Delta; 2009.

Segal Z, Williams M, Teasdale J. Mindfulness-based cognitive therapy for depression. Guilford Press; 2012.

Benson H. The relaxation response: therapeutic effect. Science. 1997;278(5344):1693–7.

Article  Google Scholar 

Czamanski-Cohen J, Wiley JF, Sela N, Caspi O, Weihs K. The role of emotional processing in art therapy (REPAT) for breast cancer patients. J Psychosoc Oncol. 2019;37(5):586–98.

Article  PubMed  Google Scholar 

Palgi Y, Shrira A, Ring L, Bodner E, Avidor S, Bergman Y, et al. The loneliness pandemic: Loneliness and other concomitants of depression, anxiety and their comorbidity during the COVID-19 outbreak. J Affect Disord. 2020;275:109–11.

Article  CAS  PubMed  PubMed Central  Google Scholar